Literature DB >> 10066218

Treating type 2 diabetes. Study was conducted in exemplary fashion.

K M Narayan, G L Beckles, E W Gregg, D F Williamson, J Saaddine, M M Engelgau, F Vinicor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10066218      PMCID： PMC1115101          DOI： 10.1136/bmj.318.7184.666a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study.

Authors:  D M Nathan
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

2.  Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

3.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

4.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

5.  Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

Authors:  D G Maggs; T A Buchanan; C F Burant; G Cline; B Gumbiner; W A Hsueh; S Inzucchi; D Kelley; J Nolan; J M Olefsky; K S Polonsky; D Silver; T R Valiquett; G I Shulman
Journal:  Ann Intern Med       Date:  1998-02-01       Impact factor: 25.391

6.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.